Skip to main content
PAGP logo
PAGP
(NASDAQ)
Plains GP Holdings, L.P.
$24.06-- (--)
Loading... - Market loading

Plains GP Holdings, L.P. (PAGP) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Plains GP Holdings, L.P. Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Plains GP Holdings, L.P. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue44.2650.0747.3457.3442.0823.2933.6734.0626.22
Cost of Revenue40.4346.5943.9454.1438.5021.0930.0630.3123.61
Gross Profit2.683.492.763.202.512.203.613.742.61
Operating Expenses
Research & Development0.000.000.000.000.000.000.000.000.00
Selling, General & Administrative0.350.390.310.330.300.280.300.320.28
Operating Expenses1.302.321.411.651.084.591.631.581.46
Operating Income1.371.171.351.551.43-2.381.982.271.15
Other Income/Expense
Interest Income0.410.020.400.750.280.000.000.000.00
Interest Expense-0.470.38-0.390.41-0.430.440.430.430.51
Other Income/Expense0.020.100.090.260.02-0.220.260.14-0.25
Income
Income Before Tax1.401.271.361.410.71-2.612.242.410.90
Income Tax Expense0.090.200.190.250.11-0.170.180.300.94
Net Income0.260.100.200.170.06-0.570.330.33-0.73
Net Income - Continuous Operations1.300.100.201.160.06-0.570.330.33-0.73
Net Income - Discontinued Operations0.380.230.190.000.000.000.000.000.00
EBITDA2.382.682.162.781.62-1.523.273.361.90
EBIT1.430.861.251.810.840.000.000.000.00
Depreciation & Amortization0.931.031.050.970.780.660.600.520.52
Earnings Per Share
Basic EPS1.001.001.001.00--3.002.002.00-5.00
Diluted EPS1.001.001.001.00--2.002.002.00-5.00
Basic Shares Outstanding0.200.200.200.190.190.190.170.160.15
Diluted Shares Outstanding0.230.200.240.190.190.250.170.160.15

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.